Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Targeted inhibition of STATs and IRFs as a novel treatment strategy in cardiovascular disease

2015/17/B/NZ2/00967

Keywords:

STAT IRF homology modeling drug discovery atherosclerosis

Descriptors:

  • NZ2_7: Bioinformatics
  • NZ1_9: Biotechnology
  • NZ1_4: Structural biology

Panel:

NZ2 - Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology

Host institution :

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

woj. wielkopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

prof. Johannes Bluijssen (Bluyssen) 

Number of co-investigators in the project: 6

Call: OPUS 9 - announced on 2015-03-16

Amount awarded: 1 206 340 PLN

Project start date (Y-m-d): 2016-02-08

Project end date (Y-m-d): 2019-11-07

Project duration:: 45 months (the same as in the proposal)

Project status: Project settled

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Licencja akademicka PyMol + AxPyMol (5 000 PLN)
  2. Pakiet ChemOffice Professional 15 firmy CambridgeSoft (3 000 PLN)
  3. Pakiet obliczeniowy Gaussian 09 + GaussView 5.0 (12 500 PLN)
  4. Stacja robocza: komputer wieloprocesorowy z monitorem (6 000 PLN)
  5. Real Time PCR - CFX96™ Touch System firmy BioRad.
  6. Stacja robocza: komputer wieloprocesorowy z monitorem (15 000 PLN)

Information in the final report

  • Publication in academic press/journals (4)
  • Book publications / chapters in book publications (1)
  1. Direct inhibition of IRF-dependent transcriptional regulatory mechanisms associated with disease
    Authors:
    Aleksandra M. Antończyk, Bart Krist, Malgorzata Szelag, Agata Michalska, Anna Piaszyk- Borychowska, Martyna Plens- Galaska, Joanna Wesoly, Hans A. Bluyssen
    Academic press:
    Frontiers in Immunology (rok: 2019, tom: 10, strony: 1176), Wydawca: Frontiers
    Status:
    Published
    DOI:
    10.3389/fimmu.2019.01176 - link to the publication
  2. Genome-Wide Inhibition of Pro-Atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVD
    Authors:
    Martyna Plens-Galaska, Malgorzata Szelag, Aida Collado, Patrice Marques, Susana Vallejo, Mariella Ramos-González, Joanna Wesoly, Maria Jesus Sanz, Concepción Peiró, Hans A.R. Bluyssen.
    Academic press:
    Frontiers in Immunology (rok: 2018, tom: 9, strony: 2141), Wydawca: Frontiers
    Status:
    Published
    DOI:
    10.3389/fimmu.2018.02141 - link to the publication
  3. Editorial: STATs and IRFs in Innate Immunity: From Transcriptional Regulators to Therapeutic Targets
    Authors:
    Chien-Kuo Lee and Hans A. R. Bluyssen
    Academic press:
    Frontiers in Immunology (rok: 2019, tom: 10, strony: 1829), Wydawca: Frontiers
    Status:
    Published
    DOI:
    10.3389/fimmu.2019.01829 - link to the publication
  4. Signal Integration of IFN-I and IFN-II with TLR4 involves sequential recruitment of STAT1-complexes and NFκB to enhance pro-inflammatory transcription
    Authors:
    Anna Piaszyk-Borychowska, Lajos Széles, Attila Csermely, Hsin-Chien Chiang, Joanna Wesoły, Chien-Kuo Lee, Laszlo Nagy and Hans A.R. Bluyssen
    Academic press:
    Frontiers in Immunology (rok: 2019, tom: 10, strony: 1253), Wydawca: Frontiers
    Status:
    Published
    DOI:
    10.3389/fimmu.2019.01253 - link to the publication
  1. eBook: STATs and IRFs in Innate Immunity: From Transcriptional Regulators to Therapeutic Targets
    Authors:
    editors: Chien-Kuo Lee and Hans A. R. Bluyssen
    Book:
    eBook: STATs and IRFs in Innate Immunity: From Transcriptional Regulators to Therapeutic Targets (rok: 2019, tom: n/d, strony: 1-219), Wydawca: Frontiers in Immunology
    Status:
    Published